Clinical trial
Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke: an Exploratory Clinical Trial
NCT07143786 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Human Induced Neural Stem Cell-derived Exosomes for Treating Acute Ischemic Stroke: an Exploratory Clinical Trial
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- October 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 38 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
ischemic stroke, acute